نتایج جستجو برای: gleason grade group

تعداد نتایج: 1123554  

Journal: :Journal of clinical pathology 1997
M Colecchia B Frigo C Del Boca A Guardamagna A Zucchi D Colloi O Leopardi

AIMS Apoptosis in prostate cancer was evaluated after three months of combined endocrine therapy to investigate the association with tumour grade, tumour stage, and the immunohistochemical detection of p53 and bcl-2 in tumour cells before and after therapy. METHODS Twenty six formalin fixed, paraffin wax embedded core biopsies and corresponding prostatectomy specimens, excised after three mon...

2017
Mohammed Alshalalfa Gerald W. Verhaegh Ewan A. Gibb Maria Santiago-Jiménez Nicholas Erho Jennifer Jordan Kasra Yousefi Lucia L.C. Lam Tyler Kolisnik Jijumon Chelissery Roland Seiler Ashley E. Ross R. Jeffrey Karnes Edward M. Schaeffer Tamara T. Lotan Robert B. Den Stephen J. Freedland Elai Davicioni Eric A. Klein Jack A. Schalken

BACKGROUND Prostate cancer antigen 3 (PCA3) is a prostate cancer diagnostic biomarker that has been clinically validated. The limitations of the diagnostic role of PCA3 in initial biopsy and the prognostic role are not well established. Here, we elucidate the limitations of tissue PCA3 to predict high grade tumors in initial biopsy. RESULTS PCA3 has a bimodal distribution in both biopsy and r...

Journal: :The Journal of urology 1993
H Zincke

Tumor volume has been shown to be proportionate to Gleason grade, capsular penetration, seminal vesicle invasion, lymph node metastases and capsular margins of resection. Because these variables are often interrelated, it is crucial to determine which of these parameters provides independent prediction of prognosis in prostate cancer. The current study analyzed 185 men who underwent radial retr...

Journal: :Medical image analysis 2013
Rachel Sparks Anant Madabhushi

Object morphology, defined as shape and size characteristics, observed on medical imagery is often an important marker for disease presence and/or aggressiveness. In the context of prostate cancer histopathology, gland morphology is an integral component of the Gleason grading system which enables discrimination between low and high grade disease. However, clinicians are often unable to disting...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009
Elizabeth A Platz Cathee Till Phyllis J Goodman Howard L Parnes William D Figg Demetrius Albanes Marian L Neuhouser Eric A Klein Ian M Thompson Alan R Kristal

BACKGROUND Several prospective studies suggest that use of cholesterol-lowering statin drugs is inversely associated with advanced stage and possibly high-grade prostate cancer. One study reported that men with low cholesterol had a lower risk of high-grade prostate cancer. Given these findings, we investigated the association between low serum cholesterol and prostate cancer risk in the Prosta...

Journal: :BJU international 2015
Charlotte F Kweldam Mark F Wildhagen Chris H Bangma Geert J L H van Leenders

OBJECTIVES To assess the metastasis-free survival (MFS) and disease-specific survival (DSS) in men with Gleason score ≤6 prostate cancer at radical prostatectomy (RP). PATIENTS AND METHODS We included 1101 consecutive RP patients operated between March 1985 to July 2013 at a single institution. The outcome variables were MFS and DSS. The postoperative survival was estimated by the Kaplan-Meie...

Journal: :Oncology reports 2001
D Karan S L Johansson M F Lin S K Batra

Tumor-specific antigens are usually defined by monoclonal antibodies (MAbs) and can play critical roles in the diagnosis and therapy of carcinomas. Despite advances in the understanding of the molecular genetics of human prostate carcinomas, therapeutic approaches require that tumor-specific markers, preferably on the cell surface, should be defined. In this study, we examined the expression of...

Journal: :Oncology reports 2010
Hirofumi Satake Kenji Tamura Mutsuo Furihata Takashi Anchi Hatsune Sakoda Chiaki Kawada Tatsuo Iiyama Shingo Ashida Taro Shuin

To identify molecules to serve as diagnostic markers for high-grade prostate cancer (PC) and targets for novel therapeutic drugs, we investigated the gene expression profiles of high-grade PCs using a cDNA microarray combined with laser microbeam microdissection. We subsequently confirmed that the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) was expressed exclusively in high-gr...

2011
Sara Lindstrom Fredrick Schumacher Afshan Siddiq Ruth C. Travis Daniele Campa Sonja I. Berndt W. Ryan Diver Gianluca Severi Naomi Allen Gerald Andriole Bas Bueno-de-Mesquita Stephen J. Chanock David Crawford J. Michael Gaziano Graham G. Giles Edward Giovannucci Carolyn Guo Christopher A. Haiman Richard B. Hayes Jytte Halkjaer David J. Hunter Mattias Johansson Rudolf Kaaks Laurence N. Kolonel Carmen Navarro Elio Riboli Carlotta Sacerdote Meir Stampfer Daniel O. Stram Michael J. Thun Dimitrios Trichopoulos Jarmo Virtamo Stephanie J. Weinstein Meredith Yeager Brian Henderson Jing Ma Loic Le Marchand Demetrius Albanes Peter Kraft

Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNPs) associated with prostate cancer risk. However, whether these associations can be consistently replicated, vary with disease aggressiveness (tumor stage and grade) and/or interact with non-genetic potential risk factors or other SNPs is unknown. We therefore genotyped 39 SNPs from regions ident...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید